Viewing Study NCT00381251


Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2025-12-25 @ 9:29 PM
Study NCT ID: NCT00381251
Status: COMPLETED
Last Update Posted: 2007-06-11
First Post: 2006-09-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study Comparing Bioequivalence of Two New Formulations of Premarin/MPA With Premarin/MPA Reference Formulation.
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module